NZ599379A - Administration of anti-cd3 antibodies in the treatment of autoimmune diseases - Google Patents
Administration of anti-cd3 antibodies in the treatment of autoimmune diseasesInfo
- Publication number
- NZ599379A NZ599379A NZ599379A NZ59937907A NZ599379A NZ 599379 A NZ599379 A NZ 599379A NZ 599379 A NZ599379 A NZ 599379A NZ 59937907 A NZ59937907 A NZ 59937907A NZ 599379 A NZ599379 A NZ 599379A
- Authority
- NZ
- New Zealand
- Prior art keywords
- administered
- antibodies
- treatment
- antibody
- administration
- Prior art date
Links
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92148506P | 2006-06-06 | 2006-06-06 | |
US44762806A | 2006-06-06 | 2006-06-06 | |
NZ573132A NZ573132A (en) | 2006-06-06 | 2007-06-05 | Administration of anti-cd3 antibodies in the treatment of autoimmune diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ599379A true NZ599379A (en) | 2013-08-30 |
Family
ID=49170410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ599379A NZ599379A (en) | 2006-06-06 | 2007-06-05 | Administration of anti-cd3 antibodies in the treatment of autoimmune diseases |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ599379A (en) |
-
2007
- 2007-06-05 NZ NZ599379A patent/NZ599379A/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007145941A3 (en) | Administration of anti-cd3 antibodies in the treatment of autoimmune diseases | |
JP2009539841A5 (en) | ||
AU2018263862A1 (en) | Stable formulations of programmed death receptor 1 (PD-1) antibodies and methods of use thereof | |
JP2009518441A5 (en) | ||
WO2007147090A3 (en) | Methods for the treatment of autoimmune disorders using monoclonal antibodies with reduced toxicity | |
WO2008050329A3 (en) | Novel sirnas and methods of use thereof | |
RU2014105496A (en) | WAYS TO REDUCE THE NUMBER OF EOSINOPHILS | |
JP2009500457A5 (en) | ||
CN111630070A (en) | Trispecific proteins and methods of use | |
NZ600758A (en) | Antibodies to human programmed death receptor pd-1 | |
HRP20170130T1 (en) | Methods of treating diabetes with dll4 antagonists | |
WO2007106811A3 (en) | Method and composition for treatment of renal disease with antibodies and their equivalents | |
WO2008002933A3 (en) | Combination of fcgammariib antibodies and cd20-specific antibodies and methods of use thereof | |
MX353319B (en) | Compositions and methods relating to glucagon receptor antibodies. | |
RS20060234A (en) | Fully human antibodies against human 4-1bb (cd137) | |
Shin et al. | Evaluation of dose effects of magnesium sulfate on rocuronium injection pain and hemodynamic changes by laryngoscopy and endotracheal intubation | |
MX2009006709A (en) | Methods for the treatment of il-1ã¿ related diseases. | |
JP2006506333A5 (en) | ||
JP2011507891A5 (en) | ||
JP2016501892A5 (en) | ||
WO2010054265A3 (en) | Monoclonal antibodies to fibroblast growth factor receptor 2 | |
WO2008079713A8 (en) | Methods for the treatment of lada and other adult-onset autoimmune diabetes using immunosuppressive monoclonal antibodies with reduced toxicity | |
JP2013508392A5 (en) | ||
NZ597325A (en) | Combination therapy of an afucosylated cd20 antibody with fludarabine and/or mitoxantrone | |
RU2019126781A (en) | PROTEINS BINDING GLUCAGON RECEPTORS AND METHODS OF THEIR APPLICATION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ERR | Error or correction |
Free format text: THE TITLE HAS BEEN CORRECTED TO TITLE: ADMINISTRATION OF ANTI-CD3 ANTIBODIES IN THE TREATMENT OF AUTOIMMUNE DISEASES; FILING DATE: 13 APR 2012; STATUS: PROPOSED; Effective date: 20130722 Free format text: THE INVENTOR HAS BEEN CORRECTED TO 1114346, PONATH, PAUL; 1239658, ROSENZWEIG, MICHAEL; 1239659, VAICKUS, LOUIS Effective date: 20130722 Free format text: THE MISSING INVENTOR HAS BEEN ADDED (728522, ROSENZWEIG, MICHAEL J; 861588, PONATH, PAUL D; 1239659, VAICKUS, LOUIS) Effective date: 20130722 |
|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 05 JUN 2014 BY AJ PARK Effective date: 20140203 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 05 JUN 2017 BY THOMSON REUTERS Effective date: 20140320 |
|
LAPS | Patent lapsed |